Tatjana S. Potpara, MD, PhD, FESC

TITLE

Professor in Internal Medicine/Cardiology University of Belgrade Belgrade, RS

Will We See a New Paradigm for SPAF? Which Patients Are More Likely to Benefit from FXIa Inhibition ...